IMO
Live / Registered — Registered and renewed (as of 07 May 2019)
What this means for you
Registered since 04 Nov 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Nov 2018).
Record
- Serial number
- 78277138
- Registration number
- 3528989
- Mark type
- Word mark
- Filed
- 22 Jul 2003
- Published for opposition
- 07 Sept 2004
- Registered
- 04 Nov 2008
- Next maintenance due
- 04 Nov 2018
- Attorney of record
- Mark Polyakov
Goods and services
- Class 005 — Pharmaceuticals: immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation
Owner
- IDERA PHARMACEUTICALS, INC., CAMBRIDGE, MA, US
- IDERA PHARMACEUTICALS, INC., CAMBRIDGE, MA, US
- Hybridon, Inc., Cambridge, MA, US
- Hybridon, Inc., Cambridge, MA, US
Prosecution history
- 07 May 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 07 May 2019 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 07 May 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 07 May 2019 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 07 Nov 2018 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 07 Nov 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Oct 2018 — TEAS SECTION 8 & 9 RECEIVED
- 04 Nov 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 14 Jun 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 14 Jun 2014 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 14 Jun 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 May 2014 — TEAS SECTION 8 RECEIVED
- 04 Nov 2008 — REGISTERED-PRINCIPAL REGISTER
- 02 Oct 2008 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 27 Sept 2008 — ASSIGNED TO LIE